BioCryst to Present at Upcoming Investor Conferences
BioCryst Pharmaceuticals, Inc. (BCRX) will present at two upcoming healthcare conferences in March 2024, providing investors with valuable insights. The presentations will be held at the TD Cowen 44th Annual Health Care Conference and the Barclays 26th Annual Global Healthcare Conference, offering live audio webcasts and replays for interested parties.
02/21/2024 - 04:01 PM
RESEARCH TRIANGLE PARK, N.C., Feb. 21, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present at the TD Cowen 44th Annual Health Care Conference in Boston on Wednesday, March 6, 2024, at 10:30 a.m. ET and the Barclays 26th Annual Global Healthcare Conference in Miami on Tuesday, March 12, 2024, at 7:30 a.m. ET.
Links to the live audio webcasts and replays of the presentations may be accessed in the Investors & Media section of BioCryst’s website at http://www.biocryst.com .
About BioCryst Pharmaceuticals ® (berotralstat), the first oral, once-daily plasma kallikrein inhibitor, and is advancing a pipeline of small-molecule and protein therapies. For more information, please visit www.biocryst.com or follow us on LinkedIn.
BCRXW
Contact : jbluth@biocryst.com
When will BioCryst Pharmaceuticals present at the TD Cowen 44th Annual Health Care Conference?
BioCryst Pharmaceuticals will present at the TD Cowen 44th Annual Health Care Conference on Wednesday, March 6, 2024, at 10:30 a.m. ET.
Which conference will BioCryst Pharmaceuticals attend on Tuesday, March 12, 2024?
BioCryst Pharmaceuticals will attend the Barclays 26th Annual Global Healthcare Conference on Tuesday, March 12, 2024, at 7:30 a.m. ET.
Where can investors access the live audio webcasts and replays of the presentations?
Investors can access the live audio webcasts and replays of the presentations in the Investors & Media section of BioCryst's website at http://www.biocryst.com.
Biocryst Pharmaceuticals Inc.
BCRX Rankings
#4914 Ranked by Stock Gains
BCRX Stock Data
Industry
Biological Product (except Diagnostic) Manufacturing
Sector
Manufacturing
Tags
Health Technology, Biotechnology, Manufacturing, Biological Product (except Diagnostic) Manufacturing
Country
US
City
Durham
About BCRX
biocryst pharmaceuticals, a biotechnology company, designs, optimizes and develops novel small-molecule drugs that block key enzymes involved in infectious and rare diseases. founded in 1986, biocryst has more than 50 employees and is experiencing continued growth. the company’s headquarters are located in research triangle park, north carolina and its discovery center of excellence is in birmingham, alabama. with expertise in drug discovery, clinical development, regulatory affairs and product commercialization, we continue to advance our clinical programs and to generate new compounds from our own discovery engine. we are proud of our culture of engagement and accountability that rewards people for innovative thinking and achievement of key objectives. the commitment of biocryst remains unchanged. we continue to be passionate about developing and marketing novel therapeutics for patients with rare and serious diseases.
